Astera Labs shares gain more than 3% after record third quarter sales and margin expansion

Traders Union
All News
Stocks
Astera Labs surges 3.19% to $361.66

Highlights

Astera Labs reported third quarter FY25 revenue of $230.6 million, more than doubling year-over-year, with gross margin at 76.4%.
High demand for AI rack-scale connectivity and adoption across over 10 AI platforms positioned Astera Labs as a key supplier to hyperscale cloud providers.
Astera Labs stock trades near its session high with strong bullish momentum and an expected price range of $350.56 to $372.77 over the next 5 trading days.

Record revenue and cloud adoption as product demand widens

Astera Labs reported record third quarter FY25 revenue of $230.6 million, more than doubling year-over-year, driven by high demand for its AI rack-scale connectivity products. The company achieved a gross margin of 76.4% and highlighted momentum in its PCIe 6 Aries and Scorpio lines, with future expansion expected from the Scorpio X-Series and the recent Xscale Photonics acquisition. Adoption across over 10 AI platforms and its role as a key supplier to hyperscale cloud providers rounded out the set of drivers.

Anton Kharitonov, expert at Traders Union, notes that Astera Labs' rally is heavily reliant on recent bullish momentum and strong revenue growth. He remains wary of the current overbought signals and the divergence in technicals, particularly as the HMA has turned bearish. While the company's gross margin performance is notable, Kharitonov questions the sustainability of such rapid gains if momentum fades. He highlights elevated volatility and mixed indicators as warning signs for short-term investors. "Traders should remain cautious, as any break below $350.56 could quickly reverse recent gains," he advises.

Viktoras Karapetjanc, expert at Traders Union, sees Astera Labs maintaining a bullish structure after record revenue and strong adoption across AI platforms. He believes the market offers multiple setups for further growth, supported by robust demand and expansion into new product lines. Gross margins at 76.4% reinforce a confident outlook, especially as institutional adoption broadens. "With the bullish trend intact and innovation driving momentum, I expect Astera Labs to test new highs if buyers hold above $364.66," says Karapetjanc.

Sholanke Dele, market strategist, remains skeptical despite Astera Labs' strong quarterly numbers. He points to elevated intraday volatility and the risk of short-term exhaustion as concerns. The upside gap and mixed momentum indicators suggest buyers may be overextended. "I would urge caution, as further gains could stall if current sentiment fails to sustain upward momentum," Dele warns.

Mixed momentum signals as price nears resistance with volatility

Astera Labs is trading well above its 20-day ($320.72), 50-day ($308.67), and 200-day ($241.09) moving averages, signaling strong bullish momentum across short-, medium-, and long-term timeframes. The Ichimoku Kijun ($314.89) sits far below, reinforcing the positive trend. Immediate attention is on the resistance at $364.66 and support at $350.56. Momentum indicators are mixed: MACD and RSI highlight continued buying interest, while ADX and Stochastic RSI remain neutral. The Commodity Channel Index points to bullish pressure, with Bull/Bear Power confirming intraday dominance by buyers, though current overbought readings suggest a possible short-term pause. The daily gain of $11.19 (3.19%) was accompanied by an upside gap of $3.81 (1.09%). The price trades near session highs with significant intraday volatility at 5.00%. However, the HMA has turned bearish, signaling a divergence that warrants caution if momentum starts to fade.

Earlier, analysts noted that Astera Labs maintained strong bullish technical momentum, even as short-term overbought risks were developing. This latest surge amplifies that outlook, and traders should monitor for sustained moves outside the $350.56–$372.77 volatility band for the next directional signal.

Source of Data: ALAB Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.